Ayurvedic protocol in the management of diabetic dyslipidemia: Addressing gut dysbiosis and metabolic imbalance – a case report

Introduction

Diabetic dyslipidemia, characterized by elevated triglycerides, cholesterol, LDL, and low HDL, is a frequent metabolic abnormality in Type 2 Diabetes Mellitus. In India, its prevalence ranges between 60–75% among diabetics, contributing significantly to cardiovascular morbidity. Gut microbiota plays a key role in lipid metabolism through bile acid modulation, short-chain fatty acid production, and inflammatory regulation. Dysbiosis promotes hepatic lipogenesis, reduces HDL synthesis, and aggravates dyslipidemia in diabetes. Diabetic Dyslipidemia can be seen under the lens of Medorogam, arising from Agnimandya, Ama Utpatti, and Kapha Medo Dushti.